Engineering D-amino acid containing novel protease inhibitors using catalytic site architecture

被引:13
作者
Annedi, SC
Biabani, F
Poduch, E
Mannargudi, BM
Majumder, K
Wei, LH
Khayat, R
Tong, L
Kotra, LP [1 ]
机构
[1] Univ Toronto, Mol Design & Informat Technol Ctr, Toronto, ON M5S 2S2, Canada
[2] Columbia Univ, Dept Sci Biol, New York, NY 10027 USA
[3] Univ Toronto, Dept Chem, Toronto, ON M5S 2S2, Canada
基金
加拿大健康研究院;
关键词
protease inhibitors; serine proteases; D-homoserine; de novo design;
D O I
10.1016/j.bmc.2005.08.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanism of proteolysis by serine proteases is a reasonably well-understood process. Typically, a histidine residue acting as a general base deprotonates the catalytic serine residue and the hydrolytic water molecule. We disclose here, the use of an unnatural D-amino acid as a strategic residue in P1 position, designed de novo based on the architecture of the protease catalytic site to impede the catalytic histidine residue at the stage of acyl-enzyme intermediate. Several probe molecules containing D-homoserine or its derivatives at P1 position are evaluated. Compounds 1, 6, and 8-10 produced up to 57% loss of activity against chymotrypsin. More potent and specific inhibitors could be designed with structure optimization as this strategy is completely general and can be used to design inhibitors against any serine or cysteine protease. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:214 / 236
页数:23
相关论文
共 22 条
  • [1] STEREOSPECIFIC SYNTHESIS OF CHLAMYDOCIN
    BALDWIN, JE
    ADLINGTON, RM
    GODFREY, CRA
    PATEL, VK
    [J]. TETRAHEDRON, 1993, 49 (36) : 7837 - 7856
  • [2] Barrett AJ, 2004, CURR OPIN DRUG DISC, V7, P334
  • [3] Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease
    Batra, R
    Khayat, R
    Tong, L
    [J]. NATURE STRUCTURAL BIOLOGY, 2001, 8 (09) : 810 - 817
  • [4] SYNTHESIS OF (S)-2-AMINO-1,1-DIPHENYLBUTAN-4-OL - CONVERSION OF AN ALPHA-AMINO-ACID INTO AN ALPHA-(DIPHENYLMETHYL) AMINE WITHOUT LOSS OF OPTICAL PURITY
    BOYLE, PH
    DAVIS, AP
    DEMPSEY, KJ
    HOSKEN, GD
    [J]. TETRAHEDRON-ASYMMETRY, 1995, 6 (11) : 2819 - 2828
  • [5] Case D.A., 2002, AMBER 7
  • [6] Convenient synthesis of L-proline benzyl ester
    Córdova, A
    Reed, NN
    Ashley, JA
    Janda, KD
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (21) : 3119 - 3122
  • [7] DIRECT, STEREOCONTROLLED TOTAL SYNTHESIS OF 9,11-AZO ANALOG OF PROSTAGLANDIN ENDOPEROXIDE, PGH2
    COREY, EJ
    NARASAKA, K
    SHIBASAKI, M
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1976, 98 (20) : 6417 - 6418
  • [8] Proteases as drug targets
    Docherty, AJP
    Crabbe, T
    O'Connell, JP
    Groom, CR
    [J]. PROTEASES AND THE REGULATION OF BIOLOGICAL PROCESSES, 2003, 70 : 147 - 161
  • [9] PSEUDOPEPTIDE INHIBITORS OF RAS FARNESYL-PROTEIN TRANSFERASE
    GRAHAM, SL
    DESOLMS, SJ
    GIULIANI, EA
    KOHL, NE
    MOSSER, SD
    OLIFF, AI
    POMPLIANO, DL
    RANDS, E
    BRESLIN, MJ
    DEANA, AA
    GARSKY, VM
    SCHOLZ, TH
    GIBBS, JB
    SMITH, RL
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (06) : 725 - 732
  • [10] Synthesis of a conformationally constrained threonine-valine dipeptide mimetic: design of a potential inhibitor of plasminogen activator inhibitor-1
    Guzzo, PR
    Trova, MP
    Inghardt, T
    Linschoten, M
    [J]. TETRAHEDRON LETTERS, 2002, 43 (01) : 41 - 43